Free Trial

King Luther Capital Management Corp Takes $4.22 Million Position in Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background
Remove Ads

King Luther Capital Management Corp acquired a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 33,691 shares of the company's stock, valued at approximately $4,223,000. King Luther Capital Management Corp owned about 0.19% of Addus HomeCare at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ADUS. Farther Finance Advisors LLC increased its position in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after purchasing an additional 366 shares during the last quarter. Janney Montgomery Scott LLC increased its position in shares of Addus HomeCare by 2.3% during the third quarter. Janney Montgomery Scott LLC now owns 10,600 shares of the company's stock valued at $1,410,000 after acquiring an additional 234 shares during the last quarter. Assetmark Inc. increased its position in shares of Addus HomeCare by 11.5% during the third quarter. Assetmark Inc. now owns 1,169 shares of the company's stock valued at $156,000 after acquiring an additional 121 shares during the last quarter. Crossmark Global Holdings Inc. acquired a new stake in shares of Addus HomeCare during the third quarter valued at about $228,000. Finally, Los Angeles Capital Management LLC increased its position in shares of Addus HomeCare by 32.6% during the third quarter. Los Angeles Capital Management LLC now owns 11,711 shares of the company's stock valued at $1,558,000 after acquiring an additional 2,879 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Several research analysts have recently commented on ADUS shares. StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Macquarie reissued an "outperform" rating and issued a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an "outperform" rating and a $150.00 price objective for the company. Stephens reissued an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday. Finally, Oppenheimer lifted their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of "Moderate Buy" and an average price target of $132.78.

Get Our Latest Stock Report on Addus HomeCare

Insider Transactions at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.60% of the company's stock.

Addus HomeCare Stock Down 0.6 %

Addus HomeCare stock traded down $0.50 during trading on Friday, reaching $90.28. The stock had a trading volume of 207,714 shares, compared to its average volume of 146,751. The stock has a market cap of $1.64 billion, a PE ratio of 20.66, a P/E/G ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a 52-week low of $87.88 and a 52-week high of $136.72. The business has a 50 day moving average price of $115.30 and a 200 day moving average price of $123.23.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, equities analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads